CClinicalTrials.gg
Status unknownNCT05205018ReMotivateHFUpdated Nov 8, 2022

Remote Motivational Interviewing to Improve Self-care in Heart Failure Patients

An interventional study of Motivational interviewing performed remotely through videocalls in Heart Failure, sponsored by University of Rome Tor Vergata. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-08.

Sponsored by University of Rome Tor Vergata · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Nov 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
432
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate if motivational interviewing, performed remotely through videocalls, is effective to improve self-care in patients with heart failure

Read the detailed description

After signing the informed consent form, patients with heart failure will be assigned to the intervention or control group (1:1). The intervention group will receive a total of seven motivational interviewing sessions over 12 months. The control group will receive the standard care.

02

Conditions studied

  • Heart Failure

Browse trials for

Keywords

  • heart failure
  • motivational interviewing
  • self-care
  • self-management
  • behavior change
  • Video calls
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 432 is above the median of 72 across 3,736 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

University of Rome Tor Vergata is the lead sponsor of 94 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. a diagnosis of HF according to international guidelines;
  2. Class II, III or IV in the New York Heart Association (NYHA) functional;
  3. poor self-care, defined as at least two items of the Self-Care Heart Failure Index 7.2 (SCHFI 7.2) with a score of 0, 1 or 2;
  4. age ≥ 18 years;
  5. having an internet access to allow the videocalls;
  6. willingness to sign the informed consent form. -

Exclusion criteria

Exclusion Criteria:

  1. severe cognitive dysfunction, with a score 0 - 4 on the Six-item screener;
  2. acute coronary events event in the prior three months;
  3. living in nursing homes a residential settings where self-care cannot be performed;
  4. if the patient's informal caregiver is not willing to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
432 participants (estimated)

Study arms

  • Experimental
    Motivational Interviewing Arm

    This Arm will receive a remote intervention (via videacalls) based on motivational interviewing to improve self-care. The intervention will be delivered seven time over 12 months.

    Behavioral: Motivational interviewing performed remotely through videocalls

  • No intervention
    Standard care Arm

    This Arm will receive the standard of care.

Interventions

  • BehavioralMotivational interviewing performed remotely through videocalls

    Remote motivational interviewing will be performed seven time over 12 months, through videocalls. The first four interventions will be performed within two months and the following three will be performed at five, eight and eleven months from enrollment.

06

What researchers measure

Primary outcomes

  1. Self-care maintenance

    Self-care maintenance will be measured with the Self-Care Maintenance Scale of the Self-Care of Heart Failure Index v.7.2

    Time frame: 3 months from enrollment

Secondary outcomes

  1. Self-care maintenance

    Self-care maintenance will be measured with the Self-Care Maintenance Scale of the Self-Care of Heart Failure Index v.7.2

    Time frame: 6, 9 and 12 months from enrollment

  2. Self-care monitoring

    Self-care monitoring will be measured with the Self-Care Monitoring Scale of the Self-Care of Heart Failure Index v.7.2

    Time frame: 3, 6, 9 and 12 months from enrollment

  3. Self-care management

    Self-care monitoring will be measured with the Self-Care Management Scale of the Self-Care of Heart Failure Index v.7.2

    Time frame: 3, 6, 9 and 12 months from enrollment

  4. Self-Care Self-Efficacy levels

    Self-Care Self-Efficacy will be measured with the Self-Care Self-Efficacy Scale; this scale gives a score from 0 to 100 with higher score meaning higher self-care self-efficacy

    Time frame: 3, 6, 9 and 12 months from enrollment

  5. Burden of heart failure physical symptoms

    The burden of heart failure physical symptom will be measured with the Heart Failure Somatic Perception Scale

    Time frame: 3, 6, 9 and 12 months from enrollment

  6. Disease specific quality of life

    The disease-specific quality of life will be measured with the Kansas City Cardiomyopathy Questionnaire

    Time frame: 3, 6, 9 and 12 months from enrollment

  7. Caregiver contribution to heart failure self-care

    Will be evaluated with the Caregiver Contribution to Self-Care of Heart Failure Index 2

    Time frame: 3, 6, 9 and 12 months from enrollment

  8. Caregiver preparedness

    Will be evaluated with the Caregiver Preparedness Scale

    Time frame: 3, 6, 9 and 12 months from enrollment

  9. Caregiver burden

    Will be evaluated with the Caregiver Burden Inventory

    Time frame: 3, 6, 9 and 12 months from enrollment

  10. Health care service uses

    They will be evaluated with a questionnaire developed by the research team. Specifically wi will evaluate patient mortality, hospitalizations and used of emergency services.

    Time frame: 3, 6, 9 and 12 months from enrollment

  11. Patient and caregiver generic quality of life

    Generic quality of live in patients and in caregivers will be evaluated with the SF-12 Survey

    Time frame: 3, 6, 9 and 12 months from enrollment

  12. Patient and caregiver anxiety and depression

    They will ve evaluated with the Hospital Anxiety and Depression Scale

    Time frame: 3, 6, 9 and 12 months from enrollment

  13. Naturalistic decision making of patients and caregivers

    They will be evaluated with the Naturalistic Decision Making Scale (patient and caregiver version)

    Time frame: 3, 6, 9 and 12 months from enrollment

07

Study locations

1 of 1 sites recruiting
  • Hospital of Alessandria
    Alessandria, Italy
    • Tatiana Bolgeo · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05205018
Lead sponsor
University of Rome Tor Vergata
Responsible party
Ercole Vellone (Associate Professor, University of Rome Tor Vergata) — Principal investigator
First posted
Jan 24, 2022
Start date
Oct 3, 2022
Primary completion
Apr 30, 2023 (estimated)
Completion
Apr 30, 2024 (estimated)
Last update
Nov 8, 2022

Study contacts

Ercole Vellone, PhD
Contact
ercole.vellone@uniroma2.it
+393387491811
Ercole Vellone, PhD
principal investigator · University of Rome Tor Vergata

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion